Steve G. Martin, Josh Scheinfeld, and Jonathan I. Cope are men of integrity and vision. The three were able to fuse their mutual interests with their financial investment experience to create Fusion Capital Partners, LLC. The core philosophy of Fusion Capital is “building good relationships of understanding and trust is the key to building financial success.”  Most financial investment companies in today’s market are looking to invest in businesses that are involved in profitable ventures. Their goal is to make money by depending on the business in which they’ve invested to succeed. If the business fails to fare well, the investment partners will often take away their financial support. 

 Fusion’s unique approach differs from that of the traditional financier. Fusion isn’t looking to support companies that are doing well in an attempt to gain a quick win. Fusion seeks to establish long-term relationships and fully intends on partnering for the long haul. Fusion believes in being there in the good times as well as in the bad. They understand that though companies may have rocky starts or even make significant mistakes, the key to the company’s ultimate success is commitment and endurance. The race is not won by the swift and the strong but by the one who endures. Fusion is that company that endures. They look for development companies that are diamonds in the rough, pursuing technologies to advance our lives. In helping these companies achieve their goals, Fusion stands to win as well in their investments.  “It’s all about building a relationship,” says Steve Martin.  “It’s about knowing if you call, we will be there to help you through.”  It’s no surprise that companies involved with Fusion eventually succeed. Fusion’s approach creates a win - win for everyone.  

 Fusion Capital is the financial partner of Samaritan Pharmaceuticals, Inc. In establishing the Fusion relationship, Dr. Janet Greeson very eloquently explained Samaritan’s vision and direction. Dr. Greeson then worked with Fusion to build the relationship so critical to true success.  “She’s a very charismatic woman and she made Fusion feel secure in their investment” says Steve. Steve and Josh’s appreciation for Dr. Greeson was manifest when they personally became the first to contribute to the Samaritan Innovative Science Foundation founded by Dr. Greeson.  

 The Fusion Capital relationship anchors Samaritan. Though others have recognized the value and strength of Samaritan Pharmaceuticals, Fusion remains the company’s greatest supporter. Through Samaritan’s vision, goals, leadership, and commitment, they saw their diamond in the rough and knew Samaritan would grow to be a success. Today Samaritan is growing rapidly, consistently meeting and surpassing established goals and accomplishing desired achievements.  Throughout it all, Fusion has never wavered in its commitment and says they will continue to be there as Samaritan reaches it’s pinnacle and beyond.